New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
08:55 EDTNUVA
theflyonthewall.com: NuVasive sell-off on reimbursement concerns seem overdone, says Leerink
Leerink attributes yesterday's weakness in NuVasive shares to investors learning that several major insurers recently deemed the company's flagship XLIF procedure "investigational." However, the firm would continue to accumulate shares following the pullback and maintains an Outperform rating. :theflyonthewall.com



News For NUVA From The Last 14 Days
Check below for free stories on NUVA the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2010
08:08 EDTNUVA
theflyonthewall.com: NuVasive reits FY10 revenue of $480M-$500M vs. consensus of $484.18M
The Company reiterated 2010 revenue guidance of 30% – 35% growth, or $480M-$500M in revenues, and FY10 non-GAAP operating margin guidance of approximately 17%, expanding to approximately 20% in Q4 of 2010. The Company will announce complete financial and operating details of its Q4 and FY09 and give detailed guidance for 2010 after the market closes on February 25. :theflyonthewall.com
08:04 EDTNUVA
theflyonthewall.com: NuVasive reports preliminary FY09 EPS 30c-31c vs. consensus of 30c
NuVasive anticipates FY09 revenue of approximately $370M, ahead of its annual global sales meeting, which will take place January 29-30, 2010. Consensus is $366.75M :theflyonthewall.com

January 27, 2010
13:36 EDTNUVA
theflyonthewall.com: NuVasive volume and volatility elevated

Subscribe for More Information
:theflyonthewall.com